@article{103575803ae648209e462dbe876b6efb,
title = "Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study",
abstract = "Despite recent advances in the treatment of psoriasis, the therapeutic options for nail psoriasis are very limited, particularly when this is the only manifestation of the disease.",
keywords = "Humans, Immunosuppressive Agents, Nail Diseases, Ointments, Psoriasis, Tacrolimus, Humans, Immunosuppressive Agents, Nail Diseases, Ointments, Psoriasis, Tacrolimus",
author = "{De Simone}, Clara and Alessia Maiorino and Francesco Tassone and Magda D'Agostino and Giacomo Caldarola",
year = "2013",
doi = "10.1111/j.1468-3083.2012.04642.x",
language = "English",
volume = "27",
pages = "1003--1006",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598",
}